Voltar
Artigo Revisado por pares
BIBTEX RIS

Anti–CTLA-4 therapy broadens the melanoma-reactive CD8 + T cell response

2014; American Association for the Advancement of Science; Volume: 6; Issue: 254 Linguagem: Inglês

10.1126/scitranslmed.3008918

ISSN

1946-6242

Autores

Pia Kvistborg, Daisy Philips, Sander Kelderman, Lois Hageman, Christian H. Ottensmeier, Deborah Joseph-Pietras, Marij J.P. Welters, Sjoerd van der Burg, Ellen Kapiteijn, Olivier Michielin, Emanuela Romano, Carsten Linnemann, Daniel E. Speiser, Christian U. Blank, John B.A.G. Haanen, Ton N. Schumacher,

Tópico(s)

Immunotherapy and Immune Responses

Resumo

Anti–CTLA-4 treatment increases the diversity of the melanoma-specific CD8 T cell response.

Referência(s)